Production / Operations
Neural Portfolio Company Hanf.com Expands German Retail Footprint with New Muhldorf am Inn Store and Four Refurbished Locations
Neural Therapeutics Retail Expansion Confirms Growth Trajectory Ahead of Critical M&A Vote
Executive Summary
- Operational Update: Portfolio company CWE European Holdings Inc. (Hanf.com) opened a new retail store in Muhldorf am Inn, Germany.
- Refurbishments: Four existing locations (Straubing, Regensburg, Herford, Freising) have been refurbished to improve customer experience and brand visibility.
- Strategic Context: Neural Therapeutics holds 30.75% ownership in CWE with an option to acquire the remaining 69.25%. This expansion supports the scaling of the German retail footprint prior to the proposed full acquisition (Series B Transactions).
- Meeting Schedule: Shareholder meeting for approval of Series B Transactions and name change is scheduled for May 25, 2026.
Material Impact
- Incremental Growth: The store opening confirms execution of the expansion strategy announced in November 2025 and February 2026. It validates management's claim that smaller towns offer efficient market penetration opportunities.
- No Surprise Factor: This operational update was anticipated given the aggressive retail acquisition history (Bielefeld/Herford in Nov 2025) and the stated goal of scaling to support the full acquisition valuation.
- Margin Concerns Persist: While revenue growth is positive, historical data indicates a significant compression in gross margins from ~58% (FY24) to ~35% (FY25 Preliminary). This news does not address the profitability quality issue; it focuses on top-line expansion via wholesale and retail mix.
- M&A Dependency: The material value driver remains the approval of the Series B Transactions (full acquisition) on May 25, 2026. This release is a supporting narrative for that vote rather than a standalone valuation catalyst.
NURL · Price
Company Overview
- Company: Neural Therapeutics Inc., transitioning to Hanf.com Inc. upon completion of Series B Transactions.
- Flagship Project: CWE European Holdings Inc. (Hanf.com), Germany's leading CBD retailer.
- Development Status: Operating 21+ retail locations in Germany, expanding via acquisition and refurbishment. Moving from pure R&D to commercial operations through full integration of Hanf.com.
- Revenue Trajectory: FY2024 Revenue $7.1M (65% growth). FY2025 Preliminary Revenue $11.2M (58% growth).
- Profitability: FY2024 Net Income positive ($371K). FY2025 Preliminary shows normalized operating income but reported net loss due to non-recurring fees (~$600K).
More from Neural Therapeutics Inc.
Jun 12, 2026 · 07:31